HPR157 Repurposed Drugs Launched Under the AMNOG in Germany: Effects on Benefit Assessment and Price Development
Dec 1, 2022, 00:00 AM
10.1016/j.jval.2022.09.1286
https://www.valueinhealthjournal.com/article/S1098-3015(22)03491-X/fulltext
Section Title :
Section Order :
10836
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03491-X&doi=10.1016/j.jval.2022.09.1286